Standard BioTools
LAB
LAB
72 hedge funds and large institutions have $138M invested in Standard BioTools in 2023 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 16 increasing their positions, 19 reducing their positions, and 9 closing their positions.
Holders
72
Holders Change
+6
Holders Change %
+9.09%
% of All Funds
1.15%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
15
Increased
16
Reduced
19
Closed
9
Calls
$83K
Puts
$99K
Net Calls
-$16K
Net Calls Change
+$17K
Top Buyers
Top Sellers
1 |
BFM
1
Boothbay Fund Management
New York
|
$3.5M |
2 |
CP
2
Caligan Partners
New York
|
$22.1M |
3 |
NIM
3
Needham Investment Management
New York
|
$3.55M |
4 |
4
HighTower Advisors
Chicago,
Illinois
|
$559K |
5 |
5
D.E. Shaw & Co
New York
|
$419K |